Endovascular therapy options in femoro-popliteal PAD;Endovaskuläre Therapieoptionen bei femoropoplitealer pAVK

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 182, Issue 9, 2010, Pages 755-763

  Brechtel, K ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

angioplasty; interventional procedures; vascular

Indexed keywords

ARTERY DISEASE; BRACHYTHERAPY; CYTOREDUCTIVE SURGERY; DIRECTIONAL ATHERECTOMY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ENDOPROSTHESIS; ENDOVASCULAR SURGERY; HUMAN; LASER SURGERY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; ROTATIONAL ATHERECTOMY; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; BLOOD VESSEL TRANSPLANTATION; COMPARATIVE STUDY; DEVICES; EQUIPMENT DESIGN; FEMORAL ARTERY; ISCHEMIA; KINESIOTHERAPY; LASER ANGIOPLASTY; LEG; MULTIMODALITY CANCER THERAPY; POPLITEAL ARTERY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; STENT; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, LASER; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; BLOOD VESSEL PROSTHESIS IMPLANTATION; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EXERCISE THERAPY; FEMORAL ARTERY; HUMANS; ISCHEMIA; LEG; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; STENTS; VASODILATOR AGENTS; SECONDARY PREVENTION;

ANTITHROMBOCYTIC AGENT; VASODILATOR AGENT;

EID: 77956050899     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0029-1245501     Document Type: Review

References (58)

1. McDaniel M D., Cronenwett J L. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989 3 273-277
2. Weitz J I., Byrne J, Clagett G P. et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996 94 3026-3049
3. Dormandy J, Mahir M, Ascady G et al. Fate of the patient with chronic leg ischaemia. A review article. JCardiovasc Surg (Torino) 1989 30 50-57
4. Norgren L, Hiatt W R., Dormandy J A. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007 33 S1-S75
5. Hirsch A T., Haskal Z J., Hertzer N R. et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) summary of recommendations. JVasc Interv Radiol 2006 17 1383-1397; quiz 1398
6. Hirsch A T., Haskal Z J., Hertzer N R. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, TransAtlantic Inter-Society Consensus and Vascular Disease Foundation. Circulation 2006 113 e463-e654
7. Jonker F HW, Schloesser F JV, Moll F L. et al. Dynamic forces in the SFA and popliteal artery during knee flexion. Consequences of stress to consider for stent durability and design. Endovascular Today 2008 5 53-58
8. Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med 2007 12 223-234
9. Noory E, Rastan A, Schwarzwalder U et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty. JEndovasc Ther 2009 16 619-623
10. Wiesinger B, Steinkamp H, Konig C et al. Technical report and preliminary clinical data of a novel catheter for luminal re-entry after subintimal dissection. Invest Radiol 2005 40 725-728
11. Dotter C T., Judkins M P. Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of Its Application. Circulation 1964 30 654-670
12. Bown M J., Bolia A, Sutton A J. Subintimal angioplasty: meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg 2009 38 323-337
13. Charalambous N, Schafer P J., Trentmann J et al. Percutaneous Intraluminal Recanalization of Long, Chronic Superficial Femoral and Popliteal Occlusions Using the Frontrunner XP CTO Device: A Single-Center Experience. Cardiovasc Intervent Radiol 2010 33 25-33
14. Al-Ameri H, Shin V, Mayeda G S. et al. Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device. JInvasive Cardiol 2009 21 468-472
15. Al-Ameri H, Mayeda G S., Shavelle D M. Use of high-frequency vibrational energy in the treatment of peripheral chronic total occlusions. Catheter Cardiovasc Interv 2009 74 1110-1115
16. Husmann M, Federer J, Keo H H. et al. Bailout revascularization of chronic femoral artery occlusions with the new outback catheter following failed conventional endovascular intervention. JEndovasc Ther 2009 16 206-212
17. Kickuth R, Ludwig K C., Do D D. et al. Steuerung der Interventionen bei subintimaler Rekanalisation und Fenestration von Dissektionsmembranen durch einen neuartigen zweilumigen intravaskulären Ultraschallkatheter. Fortschr Rntgenstr 2006 178 898-905
18. Scheinert D, Braunlich S, Scheinert S et al. Initial clinical experience with an IVUS-guided transmembrane puncture device to facilitate recanalization of total femoral artery occlusions. EuroIntervention 2005 1 115-119
19. Clark T W., Groffsky J L., Soulen M C. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. JVasc Interv Radiol 2001 12 923-933
20. Sabeti S, Schillinger M, Amighi J et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004 232 516-521
21. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. JAm Coll Cardiol 2005 45 312-315
22. Zeller T, Tiefenbacher C, Steinkamp H J. et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). JEndovasc Ther 2008 15 390-398
23. Krankenberg H, Schluter M, Steinkamp H J. et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007 116 285-292
24. Dick P, Wallner H, Sabeti S et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009 74 1090-1095
25. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006 354 1879-1888
26. Bischoff B. RESILIENT II-1-Jahres-Ergebnisse. Randomisierte Studie zum Vergleich alleiniger PTA versus PTA plus LifeStent bei Stenosen der A. femoralis superficialis und der proximalen A. poplitea. Herz 2008 33 313
27. Bosiers M, Torsello G, Gissler H M. et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. JEndovasc Ther 2009 16 261-269
28. Berceli S A. Revision of vein bypass grafts: factors affecting durability of interventions. Semin Vasc Surg 2009 22 261-266
29. Cotroneo A R., Iezzi R. The Role of Cutting Balloon Angioplasty for the Treatment of Short Femoral Bifurcation Steno-Obstructive Disease. Cardiovasc Intervent Radiol 2010 epub ahead of print, PMID: 20098989
30. Speck U, Scheller B, Abramjuk C et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006 240 411-418
31. Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006 355 2113-2124
32. Tepe G, Zeller T, Albrecht T et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008 358 689-699
33. Duda S H., Bosiers M, Lammer J et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. JVasc Interv Radiol 2005 16 331-338
34. Duda S H., Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. JEndovasc Ther 2006 13 701-710
35. Bosiers M, Deloose K, Keirse K et al. Are drug-eluting stents the future of SFA treatment? JCardiovasc Surg 2010 51 115-119
36. Ahmadi R, Schillinger M, Maca T et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002 223 345-350
37. Saxon R R., Dake M D., Volgelzang R L. et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. JVasc Interv Radiol 2008 19 823-832
38. Jahnke T, Andresen R, Muller-Hulsbeck S et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. JVasc Interv Radiol 2003 14 41-51
39. Saxon R R., Coffman J M., Gooding J M. et al. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. JVasc Interv Radiol 2007 18 1341-1349; quiz 1350
40. Waksman R, Laird J R., Jurkovitz C T. et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. JVasc Interv Radiol 2001 12 915-921
41. Gallino A, Do D D., Alerci M et al. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. JEndovasc Ther 2004 11 595-604
42. Wolfram R M., Budinsky A C., Pokrajac B et al. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 2005 236 343-351
43. Wolfram R M., Budinsky A C., Pokrajac B et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up - prospective randomized study. Radiology 2006 240 878-884
44. Kehlbach R, Dittmann H, Schmid T et al. Early effects of rhenium-188 treatment on proliferation, migration, and matrix synthesis of cultured human aortic smooth muscle cells. Strahlenther Onkol 2006 182 164-171
45. Henning E, Dittmann H, Wiskirchen J et al. Dosisabhängige Auswirkungen des kombinierten beta-gamma-Emitters 188Rhenium auf humane Endothelzellen und humane vaskuläre glatte Muskelzellen. Fortschr Rntgenstr 2004 176 404-408
46. Ahn S S. Infrainguinal atherectomy using the Auth Rotablator. JEndovasc Surg 1995 2 317-319
47. Tielbeek A V., Vroegindeweij D, Buth J et al. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. JVasc Interv Radiol 1996 7 837-844
48. Vroegindeweij D, Tielbeek A V., Buth J et al. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. JVasc Surg 1995 21 255-268; discussion 268 259
49. Ramaiah V, Gammon R, Kiesz S et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. JEndovasc Ther 2006 13 592-602
50. Zeller T, Rastan A, Sixt S et al. Long-term results after directional atherectomy of femoro-popliteal lesions. JAm Coll Cardiol 2006 48 1573-1578
51. Schwarzwälder U, Zeller T. Debulking Procedures: Potential Device Specific Indications. Tech Vasc Interv Radiol 2010 13 43-53
52. Wissgott C, Kamusella P, Richter A et al. Behandlung von Lasionen der femoropoplitealen Arterien mittels eines neuartigen Rotationsatherektomiesystems: Erste single-center Erfahrungen mit dem Pathway PVTM Atherectomy System. Fortschr Rntgenstr 2008 180 809-815
53. Zeller T, Krankenberg H, Rastan A et al. Percutaneous rotational and aspiration atherectomy in infrainguinal peripheral arterial occlusive disease: a multicenter pilot study. JEndovasc Ther 2007 14 357-364
54. Zeller T, Krankenberg H, Steinkamp H et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. JEndovasc Ther 2009 16 653-662
55. Laird J R., Reiser C Jr, Biamino G et al. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. JCardiovasc Surg 2004 45 239-248
56. Das T S. Excimer laser-assisted angioplasty for infrainguinal artery disease. JEndovasc Ther 2009 16 II98-104
57. Scheinert D, Laird J R., Schroder M Jr et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. JEndovasc Ther 2001 8 156-166
58. Laird J R., Zeller T, Gray B H. et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. JEndovasc Ther 2006 13 1-11